APGE
Price
$43.81
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
2.53B
64 days until earnings call
ELVN
Price
$20.67
Change
-$0.85 (-3.95%)
Updated
Jun 27 closing price
Capitalization
1.22B
39 days until earnings call
Interact to see
Advertisement

APGE vs ELVN

Header iconAPGE vs ELVN Comparison
Open Charts APGE vs ELVNBanner chart's image
Apogee Therapeutics
Price$43.81
Change-$0.00 (-0.00%)
Volume$456
Capitalization2.53B
Enliven Therapeutics
Price$20.67
Change-$0.85 (-3.95%)
Volume$1.44M
Capitalization1.22B
APGE vs ELVN Comparison Chart in %
Loading...
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APGE vs. ELVN commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a Buy and ELVN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (APGE: $43.81 vs. ELVN: $20.67)
Brand notoriety: APGE and ELVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 0% vs. ELVN: 291%
Market capitalization -- APGE: $2.53B vs. ELVN: $1.22B
APGE [@Biotechnology] is valued at $2.53B. ELVN’s [@Biotechnology] market capitalization is $1.22B. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whileELVN’s FA Score has 0 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • ELVN’s FA Score: 0 green, 5 red.
According to our system of comparison, both APGE and ELVN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 5 TA indicator(s) are bullish while ELVN’s TA Score has 5 bullish TA indicator(s).

  • APGE’s TA Score: 5 bullish, 4 bearish.
  • ELVN’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, APGE is a better buy in the short-term than ELVN.

Price Growth

APGE (@Biotechnology) experienced а +4.41% price change this week, while ELVN (@Biotechnology) price change was -2.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

APGE is expected to report earnings on Sep 01, 2025.

ELVN is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($2.53B) has a higher market cap than ELVN($1.22B). APGE YTD gains are higher at: -3.289 vs. ELVN (-8.133). ELVN has higher annual earnings (EBITDA): -109.95M vs. APGE (-241.42M). APGE has more cash in the bank: 513M vs. ELVN (290M). ELVN has less debt than APGE: ELVN (365K) vs APGE (11.8M). APGE (0) and ELVN (0) have equivalent revenues.
APGEELVNAPGE / ELVN
Capitalization2.53B1.22B208%
EBITDA-241.42M-109.95M220%
Gain YTD-3.289-8.13340%
P/E RatioN/AN/A-
Revenue00-
Total Cash513M290M177%
Total Debt11.8M365K3,233%
TECHNICAL ANALYSIS
Technical Analysis
APGEELVN
RSI
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
79%
MACD
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 19 days ago
84%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 12 days ago
78%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
Aroon
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSAKX19.400.16
+0.82%
Goldman Sachs International Eq Inc A
EAALX22.110.10
+0.45%
Eaton Vance Atlanta Capital Focused Gr A
JHQAX33.010.07
+0.21%
JPMorgan Hedged Equity A
WWSAX20.060.03
+0.15%
Keeley Small Cap Fund A
SVUIX38.520.04
+0.10%
NAA SMid Cap Value Institutional

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with SYRE. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
N/A
SYRE - APGE
54%
Loosely correlated
-4.99%
CRNX - APGE
53%
Loosely correlated
-0.10%
ERAS - APGE
52%
Loosely correlated
N/A
ATXS - APGE
52%
Loosely correlated
N/A
KRYS - APGE
50%
Loosely correlated
-2.60%
More

ELVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELVN has been loosely correlated with ERAS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ELVN jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELVN
1D Price
Change %
ELVN100%
-3.95%
ERAS - ELVN
50%
Loosely correlated
N/A
DNLI - ELVN
48%
Loosely correlated
-2.69%
APGE - ELVN
47%
Loosely correlated
N/A
SYRE - ELVN
47%
Loosely correlated
-4.99%
COGT - ELVN
46%
Loosely correlated
-3.14%
More